Enzyme-linked immunosorbent assay for the diagnosis of cerebral cysticercosis.

Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis (2009) 2.06

Diagnosis of cysticercosis in endemic regions. The Cysticercosis Working Group in Peru. Lancet (1991) 1.63

Immunological and molecular diagnosis of cysticercosis. Pathog Glob Health (2012) 1.20

Anticysticercous antibodies in serum and cerebrospinal fluid in patients with cerebral cysticercosis. J Neurol Neurosurg Psychiatry (1986) 1.18

Characterization by enzyme-linked immunosorbent assay of the humoral immune response in patients with neurocysticercosis and its application in immunodiagnosis. J Clin Microbiol (1986) 1.08

A prognostic classification of cerebral cysticercosis: therapeutic implications. J Neurol Neurosurg Psychiatry (1986) 0.98

Immunodiagnosis of neurocysticercosis: ways to focus on the challenge. J Biomed Biotechnol (2011) 0.78

Cerebral cysticercosis in Mexico. Neurology (1961) 1.55

Clinical aspects of CNS cysticercosis. Arch Intern Med (1980) 1.27

Serologic cross-reactions with sera from patients with echinococcosis and cysticercosis. Am J Trop Med Hyg (1980) 1.17

Human cysticercosis: antigens, antibodies and non-responders. Clin Exp Immunol (1980) 1.17

Hydrocephalus in cerebral cysticercosis. Pathogenic and therapeutic considerations. J Neurosurg (1981) 1.10

Cysticercosis of the nervous system; diagnosis by means of the spinal fluid complement fixation test. Neurology (1956) 1.02

A new immunologic test for CNS cysticercosis. Neurology (1984) 0.95

Current prevalence and distribution of hydatidosis with special reference to the Americas. Am J Trop Med Hyg (1971) 0.94

Serodiagnosis of human cysticercosis by microplate enzyme-linked immunospecific assay (ELISA). Acta Trop (1978) 0.92

[Seroepidemiologic study of human cysticerosis in the predominantly indigenous rural Indian population of the State of Chiapas]. Arch Invest Med (Mex) (1976) 0.91

Cerebral cysticercosis. Pediatrics (1980) 0.90

Comparative evaluation of indirect haemagglutination and complement fixation tests in serodiagnosis of cysticercosis. Indian J Med Res (1975) 0.90

Neurocysticercosis: clinical manifestations and problems in diagnosis. J Assoc Physicians India (1979) 0.82

Neurological and related manifestations of cysticercosis. Trop Geogr Med (1977) 0.82

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33

Classification of primary progressive aphasia and its variants. Neurology (2011) 11.82

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain (2008) 6.29

Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci U S A (1996) 5.69

Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem (1995) 5.20

Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology (2002) 5.03

An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci U S A (1996) 4.57

In vivo nitrate reduction in relation to nitrate uptake, nitrate content, and in vitro nitrate reductase activity in intact barley seedlings. Plant Physiol (1976) 4.16

The logopenic/phonological variant of primary progressive aphasia. Neurology (2008) 3.95

Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem (1996) 3.80

Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology (2007) 3.71

Comprehensive health care reform and managed competition. N Engl J Med (1992) 3.44

Race/ethnic differences in AD survival in US Alzheimer's Disease Centers. Neurology (2007) 3.18

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology (2007) 2.65

Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology (2011) 2.61

Direct and indirect gene replacements in Aspergillus nidulans. Mol Cell Biol (1985) 2.61

Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology (2009) 2.46

Alzheimer disease and frontotemporal dementias. Behavioral distinctions. Arch Neurol (1996) 2.45

Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia. Neurology (2007) 2.43

Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology (2011) 2.42

Predictors of brain morphology for the men of the NHLBI twin study. Stroke (1999) 2.41

Behavioral disorders in the frontal and temporal variants of frontotemporal dementia. Neurology (2004) 2.37

Apathy is not depression. J Neuropsychiatry Clin Neurosci (1998) 2.24

The natural history of temporal variant frontotemporal dementia. Neurology (2005) 2.22

Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol (2001) 2.22

StuA is required for cell pattern formation in Aspergillus. Genes Dev (1992) 2.14

Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology (2005) 2.10

Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology (2007) 2.09

Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology (1998) 2.09

Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen (2008) 2.00

Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke (1998) 1.99

TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology (2010) 1.93

A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology (2005) 1.93

Visual hallucinations. Clinical occurrence and use in differential diagnosis. West J Med (1987) 1.91

Some observations on the serology of Pneumocystis carinii infections in the United States. Infect Immun (1973) 1.91

A review of serological tests for the diagnosis of hydatid disease. Bull World Health Organ (1968) 1.89

Atrophy rates of entorhinal cortex in AD and normal aging. Neurology (2003) 1.88

Behavioral features in semantic dementia vs other forms of progressive aphasias. Neurology (2006) 1.80

Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study. Arthritis Rheum (1989) 1.80

Midlife cardiovascular risk factors and brain morphology in identical older male twins. Neurology (1999) 1.79

Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology (2006) 1.78

The temporal variant of frontotemporal dementia. Brain (1997) 1.76

Immunoglobulin levels in smokers and non-smokers. Ann Allergy (1980) 1.76

Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res (1995) 1.75

Atrophy progression in semantic dementia with asymmetric temporal involvement: a tensor-based morphometry study. Neurobiol Aging (2007) 1.74

Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation (2000) 1.70

Persistence of malaria antibody in Tobago, West Indies, following eradication, as measured by the indirect hemagglutination test. Am J Trop Med Hyg (1970) 1.67

Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology (2011) 1.66

Higher atrophy rate of entorhinal cortex than hippocampus in AD. Neurology (2004) 1.64

Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects. Blood (1993) 1.62

Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect. Arch Neurol (1992) 1.59

First symptom in sporadic Creutzfeldt-Jakob disease. Neurology (2006) 1.58

IgG subclass deficiency associated with corticosteroids in obstructive lung disease. Chest (1992) 1.55

Identification of Gram negative bacteria using nanoscale silicon microcavities. J Am Chem Soc (2001) 1.55

Autonomy & the refusal of lifesaving treatment. Hastings Cent Rep (1981) 1.55

Use of the indirect hemagglutination test in some studies of seroepidemiology of amebiasis in the western hemisphere. Health Lab Sci (1970) 1.52

Efficacy of CT in distinguishing small-bowel obstruction from other causes of small-bowel dilatation. AJR Am J Roentgenol (1994) 1.51

Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood (1992) 1.51

Aspergillus SteA (sterile12-like) is a homeodomain-C2/H2-Zn+2 finger transcription factor required for sexual reproduction. Mol Microbiol (2000) 1.51

TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia. Neurology (2010) 1.49

Elevated levels of immunoglobulin E in the acute febrile mucocutaneous lymph node syndrome. Pediatr Res (1976) 1.48

Spatial cognition and the human navigation network in AD and MCI. Neurology (2007) 1.48

Position-dependent and -independent mechanisms regulate cell-specific expression of the SpoC1 gene cluster of Aspergillus nidulans. Mol Cell Biol (1987) 1.47

Evaluation of intradermal and serologic tests for the diagnosis of hydatid disease. Am J Trop Med Hyg (1966) 1.46

A modified, indirect microhemagglutination test for malaria. Am J Trop Med Hyg (1968) 1.46

Hippocampal CA1 apical neuropil atrophy in mild Alzheimer disease visualized with 7-T MRI. Neurology (2010) 1.46

Regulation of vascular endothelial growth factor expression by insulin-like growth factor I. Diabetes (1997) 1.45

Self awareness and personality change in dementia. J Neurol Neurosurg Psychiatry (2005) 1.45

Selective immunoglobulin G4 deficiency and recurrent infections of the respiratory tract. Am Rev Respir Dis (1981) 1.44

Hemispheric dominance for emotions, empathy and social behaviour: evidence from right and left handers with frontotemporal dementia. Neurocase (2001) 1.44

Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. J Biol Chem (1996) 1.43

Clinical advances in degenerative dementias. Br J Psychiatry (1997) 1.43

Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response. Am J Med (1994) 1.43

Elevated levels of gamma-E (IgE) in conditions other than classical allergy. J Allergy (1970) 1.43

StuAp is a sequence-specific transcription factor that regulates developmental complexity in Aspergillus nidulans. EMBO J (1997) 1.42

Structure and regulated expression of the SpoC1 gene cluster from Aspergillus nidulans. J Mol Biol (1984) 1.40

Bear meat trichinosis. Epidemiologic, serologic, and clinical observations from two Alaskan outbreaks. Ann Intern Med (1972) 1.40

Modulators of protein kinase C inhibit hypoxia-induced erythropoietin production. Exp Hematol (1993) 1.40

Cytomegalovirus proteins. I. Polypeptides of virions and dense bodies. J Virol (1976) 1.39

Comparison of family histories in FTLD subtypes and related tauopathies. Neurology (2005) 1.39

Prevalence of avocado allergy among atopic patients. Allergy Proc (1996) 1.38

Abnormal maxillary sinus radiographs in children: do they represent bacterial infection? Pediatrics (1990) 1.38

Isolation and transcriptional characterization of a morphological modifier: the Aspergillus nidulans stunted (stuA) gene. Mol Gen Genet (1991) 1.38

Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci (1993) 1.37

Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology (2002) 1.37

Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging. Radiology (1994) 1.37

Anatomical correlates of early mutism in progressive nonfluent aphasia. Neurology (2006) 1.36

Dementia and neurodevelopmental predisposition: cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia. Ann Neurol (2001) 1.34

Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year. Neurology (2009) 1.34

Inheritance of frontotemporal dementia. Arch Neurol (1999) 1.34

Studies on iron metabolism. V. Further observations on cow's milk-induced gastrointestinal bleeding in infants with iron-deficiency anemia. J Pediatr (1974) 1.34

Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling. J Biol Chem (1999) 1.33

Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations. Neurology (2007) 1.33

Studies on the use of the indirect hemagglutination test in the diagnosis of amebiasis. Gastroenterology (1966) 1.32

Three years of collaboration on the standardization of Chagas' disease serodiagnosis in the Americas: an appraisal. Bull Pan Am Health Organ (1986) 1.31

Cognition and white matter hyperintensities in older depressed patients. Am J Psychiatry (1996) 1.31

Brain atrophy associated with baseline and longitudinal measures of cognition. Neurobiol Aging (2009) 1.31

Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood (1986) 1.30